|
![]() |
|||
|
||||
OverviewFor some time, immunotherapy has been heralded as a breakthrough approach for cancer treatment. Although the potential of this strategy remains solid, the approach needs considerable refinement. Whilst some programmes are looking to increase the understanding of molecular and cellular mechanisms underlying the stimulation of antitumor immunity, others are trying to find the most appropriate clinical setting that will reveal the role of the immune system in combating cancer. Among the most important discoveries have been tumor-specific antigens. This thematic volume highlights some key issues and discusses where they may move forward. It has been put together by two leading cancer immunotherapists from two eminent institutions that focus on cancer research. Full Product DetailsAuthor: James Allison , Glen DranoffPublisher: Elsevier Science & Technology Imprint: Elsevier Science & Technology ISBN: 9786610635719ISBN 10: 6610635714 Pages: 400 Publication Date: 03 April 2006 Audience: General/trade , General Format: Electronic book text Publisher's Status: Active Availability: Out of stock ![]() The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |